Article

The Spokesman-Review on 2017-02-05 14:30

Motley Fool: Amgen a biotech blue chip - Sun, 05 Feb 2017 PST

With a market value recently topping $110 billion, biotechnology titan Amgen (NASDAQ: AMGN) is a blue-chip company whose stock has been held back by ...

– M.G.

Related news

Motley Fool: Blue chip biotech - Sun, 27 Oct 2019 PST The Spokesman-Review
Netherlands , Las Vegas , United States , Ireland , North Carolina
The Motley Fool Take fortmyers.floridaweekly.com
China , California , Florida , Wall Street
Motley Fool: Take a bite of this stock - Sun, 05 Apr 2020 PST The Spokesman-Review
Canada , North Carolina , Jacksonville , California , Riverside
The Motley Fool offers insight on who is buying stocks, the house edge in gambling and a biotech Seattle Times
Las Vegas , California , Santa Bárbara
Motley Fool: Cancer-fighting biotech - Sun, 30 Dec 2018 PST The Spokesman-Review
Whole Foods Market , Ohio , Guangzhou
Motley Fool: A biotech bargain? - Sun, 08 Apr 2018 PST The Spokesman-Review
Cincinnati , North Carolina , Hendersonville , Indiana , Fort Wayne
Motley Fool: A biotech bargain? - Sun, 11 Nov 2018 PST The Spokesman-Review
Europe , Ohio
Motley Fool: Gushing about oil - Sun, 05 Jul 2020 PST The Spokesman-Review
Japan , Detroit , Tacoma , Motley
Motley Fool: Playing defense - Sun, 05 Dec 2021 PST The Spokesman-Review
China , Michigan , Florida , Gainesville
Motley Fool: Turnaround in progress - Sun, 05 Feb 2023 PST The Spokesman-Review
Philadelphia , Tennessee , Maryville , Wall Street
Motley Fool: Look to biotech sector for undervalued stocks - Sun, 19 Feb 2017 PST The Spokesman-Review
Green Mountain , Michigan , Shelby , Wall Street , Honolulu
Motley Fool: A healthy CVS - Sun, 16 Jul 2023 PST The Spokesman-Review
Florida , Ocala , Illinois , Kankakee , United States
Motley Fool: Profits brewing? - Sun, 18 Apr 2021 PST The Spokesman-Review
China , Chicago , Richmond , Měcholupy